GE Healthcare Deal, Q2 Revenue Growth Drive Gene Logic Shares to 52-Week High | GenomeWeb

Shares in Gene Logic climbed nearly 27 percent over two days last week in the wake of a bioinformatics distribution agreement with GE Healthcare and a positive second-quarter earnings report.

On Tuesday, Gene Logic said that GE Healthcare would market its new Sciantis web-based gene expression analysis system in 32 countries, including Japan, where GE will serve as the exclusive distributor for the product. The news drove the company's shares up by almost 9 percent during the day to close at $3.94.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.